SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-22-014088
Filing Date
2022-05-12
Accepted
2022-05-12 16:18:26
Documents
44
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q advm-20220331.htm   iXBRL 10-Q 1076276
2 EX-31.1 advm-20220331ex311.htm EX-31.1 10186
3 EX-31.2 advm-20220331ex312.htm EX-31.2 10211
4 EX-32.1 advm-20220331ex321.htm EX-32.1 5427
5 EX-32.2 advm-20220331ex322.htm EX-32.2 5225
  Complete submission text file 0001628280-22-014088.txt   3678157

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT advm-20220331.xsd EX-101.SCH 18229
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT advm-20220331_cal.xml EX-101.CAL 48444
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT advm-20220331_def.xml EX-101.DEF 71678
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT advm-20220331_lab.xml EX-101.LAB 299665
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT advm-20220331_pre.xml EX-101.PRE 183590
38 EXTRACTED XBRL INSTANCE DOCUMENT advm-20220331_htm.xml XML 461605
Mailing Address 100 CARDINAL WAY REDWOOD CITY CA 94063
Business Address 100 CARDINAL WAY REDWOOD CITY CA 94063 (650) 649-1004
Adverum Biotechnologies, Inc. (Filer) CIK: 0001501756 (see all company filings)

IRS No.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36579 | Film No.: 22918078
SIC: 2836 Biological Products, (No Diagnostic Substances)